Taylor Frigon Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-27,946
Closed -$973K 92
2020
Q3
$973K Buy
27,946
+730
+3% +$25.6K 0.43% 75
2020
Q2
$844K Buy
27,216
+1,902
+8% +$64.6K 0.42% 77
2020
Q1
$784K Buy
25,314
+95
+0.4% +$3.24K 0.61% 63
2019
Q4
$937K Sell
25,219
-97
-0.4% -$3.46K 0.65% 74
2019
Q3
$863K Sell
25,316
-105
-0.4% -$3.82K 0.62% 80
2019
Q2
$1.04M Sell
25,421
-473
-2% -$18.8K 0.72% 61
2019
Q1
$1.04M Sell
25,894
-1,157
-4% -$46.3K 0.81% 61
2018
Q4
$1.12M Buy
27,051
+6
+0% +$249 0.99% 45
2018
Q3
$1.13M Sell
27,045
-300
-1% -$11.5K 0.86% 50
2018
Q2
$941K Sell
27,345
-1,840
-6% -$62.9K 0.68% 66
2018
Q1
$983K Sell
29,185
-447
-2% -$15.4K 0.76% 61
2017
Q4
$1.02M Buy
+29,632
New +$1.01M 0.82% 64
2016
Q2
$890K Buy
26,638
+461
+2% +$14.7K 0.93% 51
2016
Q1
$736K Sell
26,177
-166
-0.6% -$4.74K 0.78% 64
2015
Q4
$791K Buy
26,343
+252
+1% +$7.93K 0.89% 52
2015
Q3
$786K Buy
26,091
+1,208
+5% +$38.7K 0.87% 52
2015
Q2
$799K Sell
24,883
-4,598
-16% -$150K 0.83% 56
2015
Q1
$968K Sell
29,481
-11
-0% -$350 0.89% 63
2014
Q4
$872K Buy
+29,492
New +$846K 0.82% 69

Other funds holding PFE

Taylor Frigon Capital Management's PFE Position: Q4 2020 in Review

Taylor Frigon Capital Management sold out of Pfizer (PFE) in Q4 2020, closing a stake of 27,946 shares — an estimated $973K sold.

Taylor Frigon Capital Management first reported a position in PFE in Q4 2014 and held it in 19 quarters. The position peaked at $1.13M in Q3 2018. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • Taylor Frigon Capital Management reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
  • Taylor Frigon Capital Management sold 27,946 Pfizer shares in Q4 2020, an estimated $973K.
  • Taylor Frigon Capital Management first reported a position in Pfizer in Q4 2014 and held it in 19 quarters.
  • Taylor Frigon Capital Management's Pfizer position peaked at $1.13M in Q3 2018.
  • 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Taylor Frigon Capital Management's 13F filing for Q4 2020, filed 22 Jan 2021.